Xencor (NASDAQ:XNCR – Free Report) had its price target increased by Piper Sandler from $42.00 to $45.00 in a report released on Monday, FlyOnTheWall reports. A number of other research analysts have also issued reports on the stock. Wedbush restated an outperform rating and issued a $37.00 target price on shares of Xencor in a […]
Brokerages Set Xencor, Inc. (NASDAQ:XNCR) Price Target at $45.00 themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Xencor (NASDAQ:XNCR – Free Report) had its price objective hoisted by Piper Sandler from $42.00 to $45.00 in a research note released on Monday morning, FlyOnTheWall reports. A number of other research analysts also recently issued reports on XNCR. Cantor Fitzgerald restated an overweight rating on shares of Xencor in a research report on Monday, […]
Shares of Xencor, Inc. (NASDAQ:XNCR – Get Free Report) have been given an average rating of “Buy” by the twelve brokerages that are currently covering the firm, MarketBeat reports. Eleven investment analysts have rated the stock with a buy recommendation and one has assigned a strong buy recommendation to the company. The average 12 month […]
Xencor (NASDAQ:XNCR – Get Free Report) posted its quarterly earnings data on Thursday. The biopharmaceutical company reported ($0.37) EPS for the quarter, topping the consensus estimate of ($0.91) by $0.54, Briefing.com reports. The firm had revenue of $45.52 million during the quarter, compared to analyst estimates of $26.25 million. Xencor had a negative return on […]